Is the hypotension of cirrhosis a GABA‐mediated process?

Hepatology

Volumn 8, Issue 1, 1988, Pages 73-77

  Minuk, Gerald Y ^a   Maccannell, Keith L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; NEUROTRANSMITTER;

BLOOD PRESSURE; CHRONIC LIVER DISEASE; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ANIMAL; BLOOD PRESSURE; DOGS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; SUPPORT, NON-U.S. GOV'T;

EID: 0023930322     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080115     Document Type: Article

References (36)

1. Electrolyte and circulatory changes in terminal liver failure
2. Studies of the cardiovascular system in the hypotension of liver failure
3. Circulatory changes in liver disease
4. General and regional circulatory alterations in cirrhosis of the liver
5. Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion
6. False neurotransmitters and hepatic failure
7. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis:plasma norepinephrine concentration, hepatic extraction and renal release
8. The gut hormone profile of fulminant hepatic failure
9. Kallikrein‐kinin and renin‐angiotensin systems in functional renal failure of cirrhosis of the liver
10. Amino acids in liver disease
11. The renal kallikrein‐kinin system: description and relationship to liver disease
12. Colonic bacteria:a source of γ‐aminobutyric acid in blood
13. γ‐Aminobutyric acid (GABA) production in small and large intestine of conventional and germ‐free Wistar rats:influence of food intake and intestinal flora
14. Metabolism of the inhibitory neurotransmitter γ‐aminobutyric acid in a rabbit model of fulminant hepatic failure
15. Identification of an acceptor system for γ‐aminobutyric acid on isolated rat hepatocytes
16. Serum levels of gamma‐aminobutyric acid‐like activity in patients with acute and chronic hepatocellular diseases
17. Serum gamma‐aminobutyric acid (GABA) levels in patients with hepatic encephalopathy
18. Elevated serum γ‐aminobutyric acid levels in children with Reye's syndrome
19. Brain GABA receptor binding and plasma GABA‐like activity in a model of chronic hepatic encephalopathy in rats (Abstract)
20. Two actions of γ‐aminobutyric acid on the responses of the isolated basilar artery from the rabbit
21. Pharmacological characterization of GABA receptors mediating vasodilation of cerebral arteries in vitro
22. γ‐Aminobutyric acid receptor on vascular smooth muscle of dog cerebral arteries
23. Elevation of brain GABA content by chronic low‐dosage administration of hydrazine, a metabolite of isoniazid
24. The central hypotensive action of baclofen in the anaesthetized cat
25. Cardiovascular effects of GABA, GABA‐aminotrans‐ferase inhibitors and valproic acid following systemic administration in rats, cats and dogs:pharmacological approach to localize the site of action
26. Central site involved in the hypotensive effects of muscimol
27. Depressor effects of isoguvacine propyl ester and isoarecaidine propyl ester due to stimulation of central GABA receptors in the cat
28. Hypotensive and postural effects of the γ‐aminobutyric acid agonist muscimol and of clonidine
29. Evidence that a GABAergic mechanism influences the development of doca‐salt hypertension in the rat
30. Gamma aminobutyric acid:circulatory and respiratory effects in different species; re‐investigation of the anti‐strychnine action in mice
31. GABA receptors mediate cerebral vasodilation in the unanesthetized goat
32. Transport of GABA at the blood‐CSF interface
33. B receptor binding sites on rat whole brain in synaptic membranes
34. Bicuculline‐insensitive GABA receptors on peripheral autonomic nerve terminals